Hepatitis B Virus
HBV vaccine nonresponders should be considered for revaccination after HCV cure
People who were not responsive to hepatitis B vaccination should be considered for revaccination following hepatitis C cure, researchers reported.
Scaling up HBV birth dose vaccine coverage could help avert more than 500,000 deaths
Bolstering the introduction of hepatitis B birth dose vaccines and verifying progress in eliminating mother-to-child transmission are among strategies critical to achieving hepatitis B virus control in Africa, WHO and CDC researchers wrote.
JNJ-3989 reduces HBsAg, may improve immune control in patients with chronic HBV infection
The small-interfering RNA JNJ-3989 induced a dose-dependent response for meeting nucleos(t)ide analogue-stopping criteria in patients with chronic hepatitis B virus infection, although hepatitis B surface antigen seroclearance was rare.
‘We’re not waiting’: World Hepatitis Day pushes for urgent elimination of viral hepatitis
On Friday, clinicians and researchers across the world recognized World Hepatitis Day as an opportunity to honor the “more than a million lives lost to hepatitis” every year and redouble national efforts to stop its spread.
EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda
EASL Congress 2023 has ended but, as the society’s official media partner, Healio was at the forefront covering the latest in liver disease. Wondering what you may have missed? Healio recaps the biggest news disrupting the specialty.
Lonafarnib regimens ‘exceed end-of-treatment response’; oral therapy may be viable in HDV
Treatment with lonafarnib boosted with ritonavir, with or without peginterferon alfa, resulted in significant virological and biochemical response in patients with chronic hepatitis D virus infection, according to data presented.
Chronic HBV infection linked to increased risk for intracerebral hemorrhage
Chronic hepatitis B virus infection was significantly associated with an increased risk for intracerebral hemorrhage but not other types of stroke in Chinese adults, according to data presented at the EASL Congress.
Behavioral data ‘has the potential’ to predict HCC in patients with hepatitis B
Scoring systems based on behavioral and clinical data outperformed existing scores in predicting risk for hepatocellular carcinoma in patients with chronic hepatitis B virus infection, according to data presented at the EASL Congress.
Lower diagnostic costs needed for HBV peripartum antiviral prophylaxis to be effective
The addition of peripartum antiviral prophylaxis to reduce neonatal hepatitis B virus infection could have “substantial extra health benefits,” although decreased diagnostic costs are needed to make this strategy cost-effective.
VIDEO: Prevention ‘always better than a cure’ for hepatitis B virus infection
In a Healio video exclusive, Jeff Baxter, president and CEO of VBI Vaccines, discusses the current burden of hepatitis B virus infection and shares updates on prevention and treatment strategies for Hepatitis Awareness Month.